Page 9 - Junshi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study

United statesSan franciscoJunshi bioscienceJunshi biosciencesZhi liGlobal researchIr teamDrug administrationData monitoring committeeNational reimbursement drug listEuropean medicines agencyPr teamChinese people liberation armyHealthcare products regulatory agencyChinese society of clinical oncologyDepartment of oncology

Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

- Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with toripalimab plus chemotherapy significantly prolongs survival in patients with advanced NPC - SHANGHAI, China

United statesDennis riedlPatricia keeganJunshi bioscienceJunshi topalliance biosciencesMarek ciszewskiRosh diasJodi sieversJunshi biosciencesCoherus biosciencesZhi liExchange commission onIr teamCoherus biosciences incExchange commissionVp corporate communications

Coherus (CHRS) and Junshi Report Positive Final Overall Survival Results of JUPITER-02

Coherus (CHRS) and Junshi Report Positive Final Overall Survival Results of JUPITER-02
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoPatricia keeganJunshi bioscienceJunshi topalliance biosciencesMarek ciszewskiRosh diasJodi sieversJunshi biosciencesCoherus biosciencesZhi liExchange commission onIr teamCoherus biosciences incShanghai junshi biosciences co ltdExchange commission

Junshi Biosciences Announces Approval for Marketing of VV116 in China

Junshi Biosciences Announces Approval for Marketing of VV116 in China - read this article along with other careers information, tips and advice on BioSpace

United statesSan franciscoJunshi bioscienceJunshi biosciencesZhi liActa pharmacologica sinicaIr teamLaboratory of the ministry scienceCentral asian centerChinese academy of sciencesXinjiang technical institute of physicsLingang laboratoryNational medical products administrationPr teamVigonvita life sciences co ltdInstitute of microbiology the chinese academy

Junshi Biosciences Announces Acceptance of NDA for VV116 in China

Junshi Biosciences Announces Acceptance of NDA for VV116 in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJunshi bioscienceJunshi bioscienceszhi liJunshi biosciencesJunshi biosciences contact informationir teamNational medical products administrationPr teamInstitute of microbiology the chinese academyShanghai junshi biosciences co ltdDeuremidevir hydrobromide tabletsJunshi biosciencesfoundedChinese academyEmergency use authorizationsJunshi bioscienceszhi